Cardiovascular disease is still the leading cause of early death in Australia, while in the developing countries the prevalence of cardiovascular risk factors has increased greatly, led by demographic and economic changes. In Australia, and indeed elsewhere, better treatments mean that more people are living longer with heart disease. The burden of chronic heart disease is a national health priority here in Australia, and a target of CTC research into prevention and treatment.
The CTC's cardiovascular trials evaluate medicines for prevention of cardiovascular diseases. Our research has influenced health outcomes globally, particularly in the treatment of acute myocardial infarction and the prevention of chronic heart disease.
Most of our research consists of large national and international projects undertaken in collaboration with many clinical research investigators and drug companies. Our research focuses on:
We are partnered with the National Health and Medical Research Council, the National Natural Science Foundation of China, and JDRF Australia.
For more information, contact the Cardiovascular Director, Tony Keech.
